Sign in

CIK 0001690585 · Non-accelerated filer<br>Smaller reporting company

Dianthus Therapeutics, Inc. /DE/

Sign in to watch
Ticker
DNTH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
929-999-4055
Business address
7 TIMES SQUARE, 43RD FLOOR, NEW YORK, NY, 10036
Former names
Magenta Therapeutics, Inc.
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 3 Insider Initial Statement of Ownership
  5. 5 Insider Annual Insider Trading Report
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Open-market sale See Remarks sold 11,200 shares at $15.25 ($170,800)
  12. 4 Open-market sale Chief Medical Officer sold 11,294 shares at $15.04 ($169,817)
  13. 4 Open-market sale See Remarks sold 2,800 shares at $15.10 ($42,280)
  14. 4/A Open-market sale See Remarks sold 12,083 shares at an average $16.01 ($193,473)
  15. 4 Open-market sale Chief Business Officer sold 4,463 shares at $16.01 ($71,453)
  16. 4 Open-market sale See Remarks sold 7,902 shares at $16.00 ($126,432)
  17. 4 Open-market sale See Remarks sold 4,181 shares at $16.03 ($67,021)
  18. 4 Open-market sale Chief Business Officer sold 9,867 shares at $16.03 ($158,168)
  19. 4 Open-market sale See Remarks sold 2,897 shares at $15.10 ($43,755)
  20. 4 Open-market sale See Remarks sold 76,711 shares at $15.16 ($1,162,617)

Page 11 of 15 · 290 filings